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The glycoprotein D (gD)' of HSV is found both on the envelope of the virion
and on the surface of HSV-infected cells. The binding of neutralizing antibody
specific for gD results in the elimination ofthis virus in experimental infections
(1-6). Therefore, passive transfer of neutralizing mAb will protect mice from a
lethal challenge of HSV-1 and HSV-2 (7). A linear antigenic site at the NH2
terminus ofthe gD molecule has been identified using anti-gD antibodies, and a
synthetic peptide 23 amino acids long has been shown to mimic this site in its
antibody-binding activity. Using overlapping synthetic peptides, the 23-amino
acidpeptide fragment has been subdivided intotwo majorantigenicdeterminants
for B cells, localized in one fragment encompassing residues 1-16 and in another
fragment encompassing residues 8-23 (8, 9).
This 23-amino acid dominant B cell determinant has also been shown to be
antigenic for class II-restricted proliferating T cells (10). This is an unusual
finding since T cell and B cell antigenic sites generally do not overlap (11-16).
We were therefore interested in examining the fine specificity of these T cells,
their MHC restriction, and their response patterns to the series of antigenic
synthetic peptides previously used in the B cell studies to eventually compare
these two antigen-specific repertoires.
In the present study we found that B10.A mice immunized with the 1-23
peptide also produced T cells specific for two determinants. A T cell response
to one ofthe determinants, 1-16, of the 23-amino acid HSV peptide was found
to be MHC restricted to the I-A molecule . The response to the second ofthese
determinants, 8-23, was exclusively restricted to the I-E molecule. Using this 1-
23 HSV peptide antigen, we have found that T cell responses appear to have
the same fine specificity as B cell responses, even though T cells must also
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FIGURE 1 .
￿
Primary amino acid sequences of HSV peptides. (*) The HSV-1 sequence of gD
with Ala at residue 7 and Asp at residue 21 . ($) The HSV-2 sequence of gD with Pro at
residue 7 and Asn at residue 21. (§) A hybrid gD sequence from HSV-1 and HSV-2 with Pro
at residue 7 and Asp at residue 21 .
recognize the la molecule. Furthermore, the I-E-restricted response is MHC
degenerate in that all T cell clones specific for 8-23 responded to antigen on
APCs of different MHC haplotypes and these clones showed different antigenic
fine specificities on the different APCs. Theseresults are surprisingly reminiscent
of the findings with the COON-terminal cytochrome c-specific T cell response
(17) and are consistent with the original interpretation of the interaction of
antigen and la at the time of T cell activation (18), which has been recently
supported by physical interaction data (19-24) .
However, studies involving point mutations in the la molecules and the use of
synthetic variants of peptide antigens have led to a narrower interpretation that
the specific amino acid substitution that led to functional vs. nonfunctional
complexes also maps the critical contact sites (25-27). That is, that these amino
acids are within the agretope and desetope as such. We present evidence that at
least for the agretope, this interpretation is not sustainable.
Materials and Methods
Animals. B10/SgSn (bbbb), B10.A/SgSn (kkkd), and B10.A(5R)/SgSn (bbkd) mice
were obtained from the TheJackson Laboratory, Bar Harbor, ME . BI O.S(9R) (sskd) mice
were obtained from R. Schwartz at the National Institutes of Health and BIO .A(4R)
(kkbb) mice were obtained from K. Blank, University of Pennsylvania, Philadelphia, PA.
BALB/c (dddd) were obtained from Charles River Breeding Laboratories, Inc., Wilming-
ton, MA. Letters indicate the haplotype source of the K, I-A, I-E, and D subregion alleles
of the inurine MHC.
Antigens.
￿
Peptides were synthesized as previously described (10) and are shown in Fig.
1 . Synthesis was performed using the Merrifield solid-phase method (28). The completed
peptides were simultaneously deprotected and cleaved from the resin using anhydrous
hydrogen fluoride-containing thioanisole. The crude peptides were purified by gel
filtration on Bio-Gel P-2 or P-4 (Bio-Rad Laboratories, Richmond, CA) columns. Homo-
geneity of the peptides was demonstrated by thin-layer chromatography, amino acid
analysis, and ammo acid sequencing. The purified peptides were analyzed by thin-layer
gel chromatography using two solvent systems (1-butanol/acetic acid/water = 4:1 :1 or
etliylacetate/pyridine/acetic acid/water = 60:20:6:11), silica gel 60 precoated aluminium
sheets (Merck h Co., Inc., Rahway, NJ) and ninhydrin or chlorine-tolidine staining. Amino
acid composition was determined after acid hydrolysis in 6 N HCI at 100°C in evacuated
sealed tubes for 24 h. Amino acid analyses were carried out using a gas-phase sequencer
(model 470A; Applied Biosystems, Inc ., Foster City, CA). After lyophilization under
1-23[1]' (7 Ala, 21 Asp)
1-23[2]t (7 Pro, 21 Asn)
1-23[H]§ (7 Pro, 21 Asp)
Lys Tyr Ala Leu Ala Asp Ala
1-------- . - Pro
1---------- Pro
Ser Leu Lys Met Ala Asp Pro Asn Arg Phe Arg Gly Lys
-------------------------Asn--
-------------------------Asp_
Asp Leu
-
Pro
23
23
1-16[1] (7Ala) 1---------- Ala --------------- 16
1-16[2] (7 Pro) 1---------- Pro --------------- 16
8-23[1] (21 Asp) 8 - - - - - - - - - - - - - - - - - - - - - - - - Asp - - 23
8-23[2] (21 Asn) 8------------------------ Asn-- 23
17-23[1] (21 Asp) 17 - - - - - Asp - - 23
17-23[2] (21 Asn) 17 - - - - - Asn - - 23HEBER-KATZ ET AL.
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TABLE I
MHC Restriction andAntigen Specificity ofB10.A T Cell Hybridomas
standard conditions, the peptide content of the samples was determined by amino acid
analysis.
Lymph Node T Cell Proliferative Responses.
￿
Mice were immunized in the hind footpads
with 100 ug of 4-23(H), a hybrid of the HSV-1 and HSV-2 gD sequences (9, 10),
emulsified in CFA. 12-14 d later, popliteal and inguinal lymph nodes were removed and
T cells prepared by passing the cell suspensions over a nylon-wool column (29). T cells (4
X l05/well) were then cultured in 96-well flat-bottomed plates (Nunc, Roskilde, Denmark)
in the presence of 2 X 105 X-irradiated normal stileen cells with or without antigen. After
3 d of culture, proliferation was determined as [- H]thymidine incorporation into DNA.
Preparation of T Cell Hybridomas (17).
￿
Nylon wool-purified T cells (5 X IOc) from
peptide-immunized animals were cultured with X-irradiated syngeneic spleen cells (3,000
rad, 2 X 10') plus antigen for 3 d in 24-well plates, harvested, and mixed with the HAT-
sensitive BW5147 AKR thymoma line. Fusion was carried out with polyethylene glycol
1,000 (J. T. Baker Chemical Co., Phillipsburg, NJ), 30% (vol/vol) for 8 min. The fused
cells were then plated at a density of 5 X 105/well of a 96-well plate (Costar, Cambridge,
MA). After 6 d, hydridomas were picked and expanded in 24-well plates (Costar) and
then tested for antigen-specific growth factor production . Positive hybridomas were then
cloned by limiting dilution at 1.0, 0.5, and 0.25 cells/well .
IL-2 production was assayed by first setting up a primary culture in which 5 X 10" T
cell hybridomas were mixed with 2 X 105 X-irradiated syngeneic spleen cells with or
without antigen at a given concentration. After 2 d, the supernatant from the first culture
plate was transferred to a second plate and 4 X 10" CTLL cells (30) were added. After 2
d, the degree of CTLL stimulation was measured by [sH]thymidine incorporation into
DNA.
Antibody Blocking Experiments.
￿
mAb 17 .3 .3. (anti-I-E; reference 31) and 10.2 .16(anti-
I-A",'.'.",." ; reference 32) were used. Various concentrations of ascitic fluid were added at
the initiation of T cell cultureand blocking was determined by the percent of the response
obtained in the presence of antigen plus anti-la divided by the response with antigen
alone.
Results
BIO.A T Cell Hybridomas Are 8-23 Specific and I-E Restricted. The clonal
BIO.A T cell response to the NHz terminus of HSV gD viral glycoprotein was
examined for its MHC restriction and antigen specificity, and the assortment
relationships of the two by generating T cell hybridomas from mice immunized
with the 1-23(H) peptide. The hybridomas were selected for responsiveness to
1-23(H) in the presence of BIO.A APC. Analysis of the antigen specificity and
the MHC restriction of several of these clones (Table 1) revealed that (a) they
Cloneno.:
Antigen:
1-23
(H)
2.3.7
1-16
(2)
8-23
(1)
1-23
(H)
2.3.8
1-16
(2)
8-23
(1)
1-23
(H)
2.3.20
1-16
(2)
8-23
(1)
APC
B10.A (kkkd) 93.4* 2.5 85.8 31.9 1.3 41 .3 10.5 0.9 3.7
BIO.A(4R) (kkbb) 1.2 1.1 0.6
BIO.A(5R) (bbkd) 48.9 13.5 4.0
B10.A + 17.3.3 3.8 0.8 0.8
B10.A + 10.2.16 71 .2 25.2 7.5
BALB/c (dddd) 0.9 1.2 1.1
* cpm X 10-5278
￿
T CELL SITES ON HERPES SIMPLEX VIRUS GLYCOPROTEIN D
TABLE 11
Degree ofMHC Degeneracy Found in B10.A T Cell Hybrids
Positive
￿
Positive
￿
Positive hy-
T cell hybridomas (5 X 104 per well) were tested with 50,ug/ml of the 1-23(H)
peptide with B10.A, B10.A(5R), and B10.A(4R) APCs in the form of2 X 105 X-
irradiated spleen cells. After 2 d, supernatants were tested for IL-2 by a CTLL
assay.
could respond to the COOH-terminal 8-23 peptides, but not the NHz-terminal
1-16 peptides, and (b) they were I-E restricted. Thus, the clones could not
respond to antigen on B10.A(4R) APCs, which share only the I-A" with BIO.A
(they do not express the I-E molecule), and their antigen-specific response on
B10.A APC could be blocked by 17.3 .3, an anti-I-E k mAb, but not 10.2 .16, an
anti-I-Ak tnAb. Furthermore, these clones responded to antigen on B10.A(5R),
which share I-E determinants with B10.A. One explanation of this last result is
that it represents an MHC-degenerate response in that T cells respond to antigen
on cross-reactive I-E molecules. However, another explanation is that these T
cells recognize antigen in association with the Ea molecule, which is invariant
among all I-E (+) mouse strains. We therefore tested the response of these
hybrids to antigen on an I-E (+) APC population derived from BALB/c (Table
I). The clones did not respond to antigen in association with the I-E' molecule,
and can be explained by MHC degeneracy, and not by responsiveness to Ea.
The extent of MHC degeneracy is seen in Table II, where five separate T cell
fusions between BW5147 and B10.A T cells specific for 1-23(H) revealed 54-
100% of the clones reactive to antigen in the presence of B10.A(5R) (bbkd)
APCs. All of the clones were nonreactive to antigen on B10.A(4R) APCs,
supporting the idea that they are I-E restricted . Also, among those clones that
were negative on B10.A(5R) APCs, there were clones reactive to antigen on
BIO.S(9R) APCs (sskd) (data not shown) .
Evidence ofAntigen-Ia Interaction.
￿
To determine whether APCs of different
haplotypes could affect the expressed antigen specificity of the hybrids, we tested
the 8-23-specific T cells for their fine specificity using peptides of different
lengths and APCs from BIO.A and BIO.A(5R) mice. B10.S(9R) APCs were also
tested, but only for their ability to present the 1-23(H) peptide. Fig. 2 shows
five different B10.A 1-23(H) clones displayed with their fine specificity patterns
using two different antigen concentrations (50 and 5 ug/ml). Clones 1 and 2 are
A and 5R degenerate, clone 3 is reactive to antigen on BIO.A APC and both
allo-reactive and antigen-reactive on B10.A(5R) APCs, clone 4 is A/9R degen-
erate, and clone 5 is A/5R/9R degenerate. Comparison of the B10.A- and
B1O.A(5R)-presented response revealed clear changes in specificity with two of
Exp. hybrids on
B10.A APC
kkkd
n
hybrids on
B10.A(5R)
APC bbkd
n
brids on
B10.A(4R)
APC kkbb
n
Minimum
degeneracy
%
1 13 10 0 77
2 11 11 0 100
3 10 6 0 60
4 37 20 0 54
5 17 10 0 59HEBER-KATZ ET AL .
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FIGURE 2 .
￿
T cell hybridomas derivedfromBIO.A mice immunized with the 1-23(H) peptide .
The response of five clones to various synthetic peptides is shown in the presence of APCs
from three different mouse haplotypes . For each antigen, the lightly shaded bar on the left
represents the B10.A APC, the darker shaded bar on the right represents the B10.A(5R)
APC, and the black bar found only with no antigen or the 1-23(H) peptide represents
B10.S(9R) APC. Two different antigen concentrations are shown by the differential shading
of each bar ; thus, the darker shading of a bar represents 50 Ag/ml and the lighter shading of
a bar represents 5 lag/ml . These data represent a secondary IL-2 assay with thymidine
incorporation into proliferating IL-2 indicator cells, CTLL, and derives from an initial assay
with T cell hybridomas, x-irradiated spleen,and two concentrations ofantigen .
the clones, 2 and 5. For both of these clones the full-length peptides and the
shorter-length peptides are presented as potent antigens by the B10.A APC. The
B10.A(5R) APCs, however, showed obvious differences in their presentation of
these antigens . For clone 2, no response was detectable to the shorter peptides,
while for clone 5 a small but reproducible response was generated by 8-23(1)
and 8-23(2) on B10.A(5R) APCs . Both clones responded well to the full-length
peptides on these APCs . Considering that there appears to be one receptor that
recognizes both antigen and la, this MHC-directed antigenic fine specificity
supports in a functional way the notion that antigen and la do interact to effect
this change in specificity . The clone 5 response demonstrates the existence of an
agretope in the 8-23(2) peptide (and, of course, the presence of an epitope) as
presented on B10.A(5R) . But, the fourfold amplification seen when the 1-23(2)280
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FIGURE 3 . The proliferative re-
sponse of T cells from B10.A (top),
BIO.A(4R) (middle), and B10 (bottom)
mice immunized with the 1-23(H)
peptide. T cells were cultured with
X-irradiated spleen cells to which the
indicated synthetic peptides were
added at various concentrations to
the culture.
peptide is presented on the same APC to the same T cell clone suggests strongly
that the distal 1-7 contiguous sequence exerts a conformational effect. That this
is not an artifact due to a difference in the physical-chemical properties of these
peptides (for instance membrane solubility) is suggested by the fact that in many
cases in Fig. 2, 8-23(1) and 8-23(2) induce an equal or higher response than 1-
23(2).
The case for clone 2 is ambiguous since no response was seen to the shorter
peptides . It can broadly be argued that either no agretope exists within 8-23(I)
and 8-23(2) for BIO.A(5R) and that the 1-7 sequence supplies a functional
agretope, or that the presence of 1-7 conformationally alters the 8-23 region
resulting in a functional agretope (an extreme version of the clone 5 case). But
when the agretope is clearly located within the 8-23 sequence [BIO.A(5R) APC
with clone 5] the results, nonetheless, seem to indicate that nonlocal structure
can have a profound effect on responsiveness.
Responsiveness to the 1-16 Peptide and I-A Restriction.
￿
We also examined the
proliferative response of the whole lymph node T cell population of B10.A
(kkkd) mice immunized with 1-23(H) (Fig. 3). This population responded toHEBER-KATZ ET AL .
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FIGURE 4.
￿
The blocking of a T cell prolifer-
ative response from B10.A immunized with the
peptide 1-23(H) using anti-la antibodies. The
response to 50 jug/ml of 1-23(H), 1-16(1), and
8-23(2) is indicated (/) . Anti-I-E mAb, 17 .3 .3,
was added at the beginning of culture along
with antigen at a final concentration of 1 :1,000
(p) as was the anti-I-A mAb, 10.2.16, also at a
concentration of 1 :1,000 (®) . The numbers
above the bars indicate the percent inhibition
of the response obtained in the absence of
antibody .
synthetic peptides derived from both ends of the 23-amino acid peptide ; i .e .,
the NH2-terminal 1-16(l) peptide and the COOH-terminal 8-23(1) and (2)
peptides . Since the clonal T cell response was directed to the 8-23 peptides only,
it was curious that there was a response here to the 1-16 peptide . We were
interested in the MHC restriction of this response and also wanted to confirm
that the 8-23 response of thehybridomaTcell clones representedthe population
as a whole . Results in other T cell antigenic systems (15, 43) suggested that
separate determinants could be dissected by their differential la presentation
requirements . We therefore used anti-la antisera (Fig. 4) to determine the
contribution of the different la molecules to theT cell response to the 1-16 and
8-23 peptides . We found that the anti-I-E mAb 17.3 .3 could block the response
to 8-23 peptide, whereas the anti-I-A' mAb 10.2 .16 could not . On the other
hand, the response to 1-16 was blocked more by 10.2 .16 than by 17.3 .3 . The
response to peptide 1-23(H) was blocked to the largest extent by 17 .3 .3 . and
less by 10.2.16 . As a first approximation, it appears from these data that T cell
recognition serves to subdivide the 1-23 molecule into two parts, each associated
with a particular Ia molecule, the 1-16 determinant being recognized in associ-
ation with the I-A molecule and the 8-23 determinant being recognized in
association with the I-E molecule .
We attempted to derive further support for this association of an antigenic
determinant and a given la isotype by immunizing mice that expressed only the
I-A molecule with the 1-23(H) peptide . T cells ofB10.A(4R) (kkbb) mice (which
share the I-A' with B lO.A) and T cells ofB10 (bbbb) animals, which have an I-
A'' haplotype, were tested for proliferation to the panel of gD peptides (see Fig .
3) . T cells from both mouse strains responded to the 1-23(H) peptide but not to
the 8-23 peptides, supporting the anti-la blocking data . However, examination
of the 1-16 responses did not lead to a clear assignment . Thus, 1-16(1) stimu-
lated a BIO.A lymph node T cell response but did not stimulate a B10.A(4R)
response, which could mean that the 1-16(1) response maps to I-Ek . However,
the fact that B10.A(4R) responds to 1-16(2) can be interpreted to mean that the
1-16 response does indeed mapto I-A (in this case, specifically to I-Ak) . However,
differences in T cell repertoire, regulation, or antigen presentation, in the
absence or presence of the I-E molecule, may result in this observed 1-16 fine282
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FIGURE 5. A schematic represen-
tation of the T cell determinants
present on the 23-amino acid pep-
I
￿
a helical
￿
23
￿
tide derived from the NH 2 terminus
0AA
￿
o
￿
HSV-1 sequence
￿
of the gD from HSV-1 and HSV-2.
One determinant is found in the first
16 amino acids, 1-16, and is I-A re-
23
￿
stricted . The second determinant is
^'
￿
HSV-2 sequence
￿
found in the last 16 amino acids, 8-
I-E restricted region 2
non-helical
￿
23, and is I-E restricted . The I-A-
restricted determinant appears to be
helical, whereas the I-E-restricted de-
terminant is nonhelical (10).
specificity variance . The responses observed with B10 are consistent with the 1-
16 response mapping to I-A .
Taken together, the experiments above, with the caveats noted, provide
evidence for association between 1-16-specific T cell responses and I-A, and
between 8-23-specific T cell responses and I-E (Fig . 5) .
Discussion
In the present study, we examined theT cell response to synthetic peptides
corresponding to the NHz-terminal 23 amino acids of thegD molecule of HSV-
1 and HSV-2. This 23-amino-acid peptide has been shown to be composed of
two major antigenic determinants, coincident for both B and T cells . In the case
of B cells, mAbs made against HSV-1 and HSV-2 exist that have the same
antigenic fine specificity as the B10.A T cell hybridoma clones in that they bind
to the 8-23 peptides but not to the 12-23 or 1-16 peptides (reference 9, and
Watari, E., unpublished data) . The B cell response to the 1-16 peptide is more
difficult to induce and can only be demonstrated when animals have been
immunized with gD ofHSV-2.
In the case ofT cells, which recognize the same two determinants but in the
context of MHC, each of the two antigenic determinants functionally associates
with a different la isotype . Though a proliferativeT cell response to both the
1-16 and 8-23 determinants is seen in the B10.A 1-23(H)-primed lymph node,
the response to the 8-23 determinant appears to dominate as indicated by a
selection for only 8-23-specificT cells in the hybridomas generated . All of these
clones and the whole population of 8-23-specific T cells are I-E restricted, as
they are blocked by anti-I-E antibody .
The T cell response to the 1-16 peptide associates with the I-A molecule,
based both on antibody blocking data and on the finding that B10 andBlO.A(4R)
mice, which express only the I-A molecule, respond only to the 1-16 peptide
when immunized with 1-23(H) . Despite the proliferative response to this peptide
in a 1-23(H) peptide-primed B10.A lymph node T cell population, we were
unable to isolate any T cell hybrids with this specificity . It is possible that the 1-
16 peptide response is labile since the restimulation of an in vitro 1-23(H)
peptide-specificT cell culture is almost devoid of a 1-16 response (see reference
10) . However, consistent with the notion that the 1-16 peptide is associated with
the I-A molecule, all B10.A(5R) T cell hybridomas that are 1-16 specific are
also I-A restricted (data not shown) .HEBER-KATZ ET AL.
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Fig. 5 represents a map of the antigenic determinants, their secondary struc-
ture, and their association with Ia. Structure analysis of the peptides has been
determined both by Chou-Fasman predictive models (33) and confirmed by
circular dichroism measurements in trifluoroethanol (10). As shown previously,
we found that the 1-16 determinant is helical and immunization with a helical
peptide, in particular the 1-23(1) peptide, results in a response to the helical
part of the molecule . On the other hand, immunization with a nonhelical 1-
23(H) peptide results in a response directed mainly to a nonhelical part of the
molecule (8-23). It should be noted that in Fig. 2, the clonal 8-23-specific T cell
responses to the 1-23(1)peptide areconsistently low and we previously attributed
this to its high helical component which affects the 8-23-specific response . The
significance of a predominant secondary structure and itsassociation with a given
Ia molecule is unclear at present.
The ability of animals to recognize an antigen in association with a private
determinanton the I-E molecule is not an unusual finding; it is generally accepted
that T cells recognize antigen in association with private determinants of MHC-
encoded molecules, a phenomenon known as MHC restriction (34-37). Rather,
it is the degree of MHC degeneracy seen here that is of interest, a finding most
easily understood as structural similarities of class II antigenic determinants (38,
39). Studies by Janeway et al. (40) suggested that self-MHC restriction was so
precise that no degeneracy could be found in BALB/c anti-OVA clones, whereas
nonself-MHC degeneracy was not uncommon in alloresponses. On the other
hand, there are examples to the contrary (41-44), including the B10.A T cell
response to the COOH-terminal 81-104 peptide of the cytochrome c molecule
(17, 45, 46). In this case, MHC degeneracy is the rule since the response in the
B10.A occurs in the presence of either B10.A and B10.A(5R) APCs, or B10.A
and BIO.S(9R) and/or B10.SM APCs. The same degree of MHC degeneracy is
seen in the T cell response to the herpes gD NH2-terminal 1-23 peptides with
what appears to be the same MHC specificity.
MHC-antigen associations such as those observed with both of the 1-23
determinants could be due to the selection of the T cell repertoire through
thymic education (47), suppression (48), T cell receptor gene usage (49), or the
selective physical association of these peptides with a particular Ia molecule (18-
24), also known as determinant selection (50, 51). Our data support the last
possibility. We found that the antigen specificity pattern of an 8-23 peptide-
specific T cell changed with the MHC haplotype of theAPC, and like cytochrome
c, this is another example of a change in specificity with different APCs. In this
case, however, we have used a viral antigen to demonstrate this. We interpret
both as a manifestation of a trimolecular complex of antigen, Ia, and T cell
receptor at the time of T cell priming. One feature of this change in specificity
is that with one of the clones (clone 5), BIO.A APC presents both 1-23 and 8-
23 peptides well, whereas the BIO.A(5R) APC presents the longer 1-23 peptides
far better than the 8-23 peptides.
From the findings with cytochrome c, we identified two sites on the peptide
antigen: T cell binding (epitope) and Ia binding (agretope). In defining sites for
the peptides in the present study, we had to deal with another difference between
the herpes and the cytochrome c response. Both the antibody and the T cell284
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antiherpes response are sensitive to nonlocal structural changes in the peptides,
making analysis of these molecules in a linear, noninteractive fashion difficult
(26, 52). A linear model would predict that a mAb specific for 8-23 but not for
12-23 would almost certainly react with the 1-16 peptide, which has an 8-16
residue overlap region . This is not the case. Furthermore, the same effect is
observed at the T cell level where the B10.A response is modified by amino acids
outside of the determinant and has been related to conformational changes in
the peptides as determined by circular dichroism measurements (10).
In this paper, we have shown that it is at least the agretope that is sensitive to
conformation changes. Thus, clone 5, which recognizes 8-23(2) on B10.A(5R)
APCs, gives a fourfold enhanced response to 1-23(2) on these same APCs. We
must conclude that the most reasonable interpretation of this finding is that the
agretope and epitope are both located in the 8-23 region, but that the agretope
can be modified by the distal 1-7 sequence. The interpretation derived from
other studies using either point mutations at the la locus or synthetic variants of
peptides is that specific amino acid substitutions that lead to functional vs.
nonfunctional complexes map the critical contact sites and that these amino acids
are within the agretope and desetope as such (25-27). The conclusion cited
above argues against such a direct interpretation. Thus, changes made in given
residues resulting in a change in specificity of the T cell response may not be
mapping actual intermolecular contact points in this case.
Summary
Analysis of the B10.A T cell response to synthetic peptides representing the
NHz-terminal 23 amino acids from the HSV glycoprotein D sequence revealed
two antigenic determinants for Tcells: one localized between residues 1-16 and
the other between residues 8-23. The 1-16 site, which is helical, was recognized
in the context ofthe la molecule, whereas the 8-23 site, which is nonhelical, was
recognized in the context of the I-E molecule. The I-E-restricted response was
found to be highly MHC degenerate in that T cell hybridomas specific for the
8-23 peptide responded to antigen on APCs derived from B10.A, B10.A(5R),
and B10.A(9R) mice and showed differences in antigenic fine specificity with
AP(:s of different haplotypes. These data support the idea of antigen-la inter-
action .
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